Image-matching digital macro-slide—a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma
Open Access
- 16 March 2022
- journal article
- research article
- Published by Springer Nature in Hepatology International
- Vol. 16 (2) , 381-395
Abstract
Background: Microvascular invasion (MVI) is a prominent risk factor of postoperative recurrence for hepatocellular carcinoma (HCC). The MVI detection rate of conventional pathological examination approaches is relatively low and unsatisfactory. Methods: By integrating pathological macro-slide with whole-mount slide imaging, we first created a novel pathological examination method called image-matching digital macro-slide (IDS). Surgical samples from eligible patients were collected to make IDS. The MVI detection rates, tumor recurrence rates and recurrence-free survival were compared among conventional 3-Point and 7-Point baseline sampling protocols and IDS. Additionally, biomarkers to recognize MVI false negative patients were probed via combining conventional pathological sampling protocols and IDS. Receiver operating characteristic curve (ROC) analysis was used to obtain the optimal cutoff of biomarkers to distinguish MVI false negative patients. Results: The MVI detection rates were 21.98%, 32.97% and 63.74%, respectively, in 3-Point, 7-Point baseline sampling protocols and IDS (p < 0.001). Tumor recurrence rate of patients with MVI negative status in IDS (6.06%) was relatively lower than that of patients with MVI negative status in 3-Point (16.90%) and 7-Point (16.39%) sampling protocols. Alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) were selected as potential biomarkers to distinguish MVI false negative patients. Conclusions: Our study demonstrated that IDS can help enhance the detection rate of MVI in HCC and refine the prediction of HCC prognosis. Alpha-fetoprotein is identified as a suitable and robust biomarker to recognize MVI false-negative patients in conventional pathological protocols.Keywords
All Related Versions
Funding Information
- The key project of the National Natural Science Foundation of China (81730097)
- the Grants of the Science Fund for Creative Research Groups (81521091)
- The National Natural Science Foundation of China (81602523, 82072618)
- Shanghai Municipal Health Bureau (SHDC2020CR1004A)
This publication has 16 references indexed in Scilit:
- Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysisHepatology Research, 2018
- Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2017
- Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2016
- Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 updateWorld Journal of Gastroenterology, 2016
- Long-Term Outcomes of Repeat Hepatic Resection in Patients with Recurrent Hepatocellular Carcinoma and Analysis of Recurrent Types and Their Prognosis: A Single-Center Experience in ChinaAnnals of Surgical Oncology, 2012
- Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteriaBritish Journal of Surgery, 2011
- Quantification of prognostic immune cell markers in colorectal cancer using whole slide imaging tumor maps.2010
- Impact of Tumor Characteristic on the Outcome of Liver Transplantation in Patients With Hepatocellular CarcinomaTransplantation Proceedings, 2009
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisThe Lancet Oncology, 2009
- Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological FactorsAnnals of Surgical Oncology, 2008